Dr. George Leef Joins MyCardiologist, Bringing Expertise in Cardiac Care to Boynton Beach, FL
July 19, 2023 05:32 ET
|
My Cardiologist
MIAMI, July 19, 2023 (GLOBE NEWSWIRE) -- MyCardiologist, South Florida’s leading provider of comprehensive cardiovascular care and services, is thrilled to welcome Dr. George Leef, M.D. as the...
Baanbrekend werk voor de toekomst van de cardiologie: PMcardio bundelt krachten met het Hartcentrum Aalst in een AI-gedreven R&D-partnerschap
July 18, 2023 10:25 ET
|
Powerful Medical
AALST, België, July 18, 2023 (GLOBE NEWSWIRE) -- PMcardio, een marktleider in AI-aangedreven cardiovasculaire diagnostiek, is verheugd een onderzoeks- en ontwikkelingspartnerschap aan te...
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
July 17, 2023 09:00 ET
|
Blue Water Biotech, Inc.
CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...
ŌNŌCOR signs an exclusive US distribution agreement with B. Braun Interventional Systems
July 17, 2023 08:29 ET
|
ONOCOR
PHILADELPHIA, July 17, 2023 (GLOBE NEWSWIRE) -- ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other facilitating technologies for the modern-day...
Pioneering the Future of Cardiology: PMcardio Joins Forces with Cardiovascular Research Center Aalst in an AI-Driven R&D Partnership
July 17, 2023 08:04 ET
|
Powerful Medical
AALST, Belgium, July 17, 2023 (GLOBE NEWSWIRE) -- PMcardio, a market leader in AI-powered cardiovascular diagnostics, is thrilled to announce a research and development partnership with the...
Revolutionäre KI-gestützte Diagnostikplattform PMcardio jetzt in 15 weiteren europäischen Märkten für medizinische Fachkräfte zugänglich
July 11, 2023 03:04 ET
|
Powerful Medical
LONDON, July 11, 2023 (GLOBE NEWSWIRE) -- PMcardio, Markführer im Bereich der KI-gestützten Diagnostik von Herz-Kreislauf-Erkrankungen, gibt mit der Einführung seiner neuesten Version des Produkts...
PMcardio, la plateforme de diagnostic révolutionnaire alimentée par l'IA, est désormais accessible aux professionnels de la santé sur 15 nouveaux marchés européens
July 11, 2023 03:04 ET
|
Powerful Medical
LONDRES, 11 juill. 2023 (GLOBE NEWSWIRE) -- PMcardio, entreprise leader du diagnostic des maladies cardiovasculaires basé sur l'IA, annonce son expansion sur 15 marchés européens supplémentaires...
Revolutionary AI-Powered Diagnostics Platform PMcardio Now Accessible to Healthcare Professionals in 15 New European Markets
July 11, 2023 03:04 ET
|
Powerful Medical
LONDON, July 11, 2023 (GLOBE NEWSWIRE) -- PMcardio, a leading force in AI-powered diagnostics for cardiovascular diseases, announces expansion into 15 additional European markets with the launch of...
ZyVersa Therapeutics Announces Publication in the Journal Circulation That Demonstrates the Role of Inflammasome Activation in Hypertrophic Heart Disease Induced by Mechanical Stress
July 10, 2023 07:37 ET
|
ZyVersa Therapeutics
Mechanical stress on the heart, such as high blood pressure, initiates NLRP3-induced inflammation through heart-brain interactions, causing heart enlargement (hypertrophic heart disease) Mechanical...
Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products
July 06, 2023 17:05 ET
|
Blue Water Biotech, Inc.
CINCINNATI, July 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology and pharmaceutical company focused on developing and...